427 related articles for article (PubMed ID: 26370688)
1. Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
Bailly S; Leroy O; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Azoulay E; Timsit JF
Intensive Care Med; 2015 Nov; 41(11):1931-40. PubMed ID: 26370688
[TBL] [Abstract][Full Text] [Related]
2. Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
Bailly S; Leroy O; Azoulay E; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Timsit JF;
J Infect; 2017 Apr; 74(4):408-417. PubMed ID: 28104387
[TBL] [Abstract][Full Text] [Related]
3. Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
Bailly S; Bouadma L; Azoulay E; Orgeas MG; Adrie C; Souweine B; Schwebel C; Maubon D; Hamidfar-Roy R; Darmon M; Wolff M; Cornet M; Timsit JF
Am J Respir Crit Care Med; 2015 May; 191(10):1139-46. PubMed ID: 25780856
[TBL] [Abstract][Full Text] [Related]
4. Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units.
Montravers P; Perrigault PF; Timsit JF; Mira JP; Lortholary O; Leroy O; Gangneux JP; Guillemot D; Bensoussan C; Bailly S; Azoulay E; Constantin JM; Dupont H;
Clin Microbiol Infect; 2017 Feb; 23(2):117.e1-117.e8. PubMed ID: 27746395
[TBL] [Abstract][Full Text] [Related]
5. Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3):135-49. PubMed ID: 23727234
[TBL] [Abstract][Full Text] [Related]
6. [Antifungal treatment for suspected or proved candidiasis in the critically ill].
Massanet P; Jung B; Molinari N; Villiet M; Moulaire V; Roch-Torreilles I; Jaber S; Reynes J; Corne P
Ann Fr Anesth Reanim; 2014 Apr; 33(4):232-9. PubMed ID: 24684836
[TBL] [Abstract][Full Text] [Related]
7. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non- neutropenic critically ill adult patients.
Epico Project Group
Rev Esp Quimioter; 2013 Jun; 26(2):131-50. PubMed ID: 23817652
[TBL] [Abstract][Full Text] [Related]
8. [Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3 Suppl 1):135-49. PubMed ID: 23764554
[TBL] [Abstract][Full Text] [Related]
9. Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.
van der Geest PJ; Rijnders BJ; Vonk AG; Groeneveld AB
Mycoses; 2016 Mar; 59(3):179-85. PubMed ID: 26707572
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for invasive candidiasis in China.
Chen D; Wan X; Kruger E; Chen C; Yue X; Wang L; Wu J
J Med Econ; 2018 Mar; 21(3):301-307. PubMed ID: 29303621
[TBL] [Abstract][Full Text] [Related]
11. ÉPICO project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Esp Anestesiol Reanim; 2013; 60(7):e1-e18. PubMed ID: 23911095
[TBL] [Abstract][Full Text] [Related]
12. Impact of initial empirical antifungal agents on the outcome of critically ill patients with invasive candidiasis: analysis of the China-SCAN study.
Cui N; Wang H; Qiu H; Li R; Liu D
Int J Antimicrob Agents; 2017 Jul; 50(1):74-80. PubMed ID: 28499959
[TBL] [Abstract][Full Text] [Related]
13. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M;
JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483
[TBL] [Abstract][Full Text] [Related]
14. Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients.
Reboli AC; Rotstein C; Kett DH; Maschio M; Cartier S; Chambers R; Tarallo M
Pharmacoeconomics; 2011 Aug; 29(8):705-17. PubMed ID: 21591820
[TBL] [Abstract][Full Text] [Related]
15. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
DiNubile MJ; Lupinacci RJ; Strohmaier KM; Sable CA; Kartsonis NA
J Crit Care; 2007 Sep; 22(3):237-44. PubMed ID: 17869975
[TBL] [Abstract][Full Text] [Related]
16. Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.
Kett DH; Shorr AF; Reboli AC; Reisman AL; Biswas P; Schlamm HT
Crit Care; 2011; 15(5):R253. PubMed ID: 22026929
[TBL] [Abstract][Full Text] [Related]
17. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
[TBL] [Abstract][Full Text] [Related]
18. MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.
Ostrosky-Zeichner L; Shoham S; Vazquez J; Reboli A; Betts R; Barron MA; Schuster M; Judson MA; Revankar SG; Caeiro JP; Mangino JE; Mushatt D; Bedimo R; Freifeld A; Nguyen MH; Kauffman CA; Dismukes WE; Westfall AO; Deerman JB; Wood C; Sobel JD; Pappas PG
Clin Infect Dis; 2014 May; 58(9):1219-26. PubMed ID: 24550378
[TBL] [Abstract][Full Text] [Related]
19. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
20. Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
Ruhnke M; Paiva JA; Meersseman W; Pachl J; Grigoras I; Sganga G; Menichetti F; Montravers P; Auzinger G; Dimopoulos G; Borges Sá M; Miller PJ; Marček T; Kantecki M
Clin Microbiol Infect; 2012 Jul; 18(7):680-7. PubMed ID: 22404732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
